Transamination and Oxidative Decarboxylation Rates of Branched-Chain 2-0X0 Acids in Cultured Human Skin Fibroblasts

Transamination and Oxidative Decarboxylation Rates of Branched-Chain 2-0X0 Acids in Cultured Human Skin Fibroblasts

003 1-3998/88/230 I -0040$02.00/0 PEDIATRIC RESEARCH Vol. 23, No. 1, 1988 Copyright O 1988 International Pediatric Research Foundation, Inc. Prinfed in (I.S.A. Transamination and Oxidative Decarboxylation Rates of Branched-Chain 2-0x0 Acids in Cultured Human Skin Fibroblasts PETER SCHADEWALDT, WOLFGANG RADECK, HANS-WERNER HAMMEN, AND UDO WENDEL Institut fur Physiologische Chernie II [P.S., W.R., H- W.H.]and Kinderklinik C /U. W.], Universitiit Diisseldorf; Moorenstr. 5, 0-4000 Diisseldorf; FRG ABSTRACT. Transamination and oxidative decarboxyla- acids derived from L-leucine and/or L-valine have been used as tion of branched-chain L-amino acid derived 2-0x0 aqids in substrates. In few studies, (S)- or unspecified (R,S)-3-methyl-2- cultured human skin fibroblasts from normal subjects and oxopentanoate have been used as we11 (16- 19). However, (R)-3- from a patient with maple syrup urine disease (variant methyl-2-oxopentanoate metabolism has not been examined. form) were comparatively studied in incubations with 1- The aim of the present study was to get further insight into L- I4C-labeled substrates (1 mmol/liter). With normal cells, allo-isoleucine metabolism in man. We therefore studied 1) I4CO2release ranged from about 11 to 3 nmol/90 min/mg oxidative decarboxylation rates of all four branched-chain 2-0x0 of cell protein in the order 3-methyl-2-oxo['4CJbutanoate acids in intact skin fibroblasts derived from normal subjects and > (S)-3-methyl-2-oxo[vpentanoate > 4-methyl-2- from a patient with variant MSUD and 2) 2-0x0 acid transami- ~xo['~C]pentanoate> (R)-3-methyl-2-oxo[~pentanoate. nation, since amination of (R)-3-methyl-2-oxopentanoate is the Formation of the corresponding branched-chain amino[I4C] only way for L-allo-isoleucine formation in vivo. acids was substantially higher than I4CO2 production (around 10-fold) and similar with L-valine, L-isoleucine, MATERIALS AND METHODS and L-leucine. L-Allo-isoleucine production [from (R)-3- methyl-2-oxopentanoate] was significantly lower. With ma- Chemicals. L-[l-14C]leucine(2.1 GBq/mmol), L-[l-14C]valine ple syrup urine disease fibroblasts, comparable transami- (2.0 GBq/mmol), and sodium [l-14C]pyruvate(340 MBq/mmol) nation rates were observed. Related to the findings with were from New England Nuclear, Dreieich, KI4CN (370 MBq/ normal cells, I4CO2release from each substrate was differ- mmol), NaHI4CO3 (2.1 GBq/mmol), and [methyl-'4C]toluene ently reduced and apparent residual branched-chain 2-0x0 standard were obtained from Amersham-Buchler,Braunschweig. acid dehydrogenase complex activity with 3-methyl-2-0~- Enzymes and coenzymes were from Boehringer, Mannheim, obutanoate, 4-methyl-2-oxopentanoate, (S)-, and (R)-3- Acylase I (EC 3.5.1.14) was from Sigma, Deisenhofen, and methyl-2-oxopentanoate amounted to 12, 13, 22, and SO%, Dowex 50 WX8 (50-100 mesh) from Serva, Heidelberg. All respectively. (Pediatr Res 23: 40-44, 1988) other chemicals were purchased in the highest available purity from Merck, Darmstadt, or Sigma. Purity of branched-chain 2- Abbreviations 0x0 acids was checked by automatic amino acid analysis and by a modification of the HPLC method described previously (20). MSUD, maple syrup urine disease A Nucleosil 5CI8 column (250 X 4 mm, Macherey-Nagel, Diiren, HPLC, high-performance liquid chromatography guard column Lichrosorb RP-18, 4 x 4 mm, Merck) and 33% PBS, phosphate-buffered saline CH3CN at 1.3 ml/min were used. The respective quinoxalinol derivatives were prepared as described previously (21). Purity was as specified by the suppliers. Unlabeled racemic (R,S)-3- methyl-2-oxopentanoate was optically inactive. In MSUD, the oxidative decarboxylation of branched-chain Branched-chain 2-0x0 acids. 2-0x0 acids from L-[l 14C]leucine 2-0x0 acids is impaired by a deficiency in branched-chain 2-0x0 and L-[l-14C]valinewere prepared as described previously (22). acid dehydrogenase activity (EC 1.2.4.4). Due to the metabolic 1-I4C-labeled (S)- (1 4.1 MBq/mmol) and (R)-3-methyl-2-0x0- block and normal aminotransferase activities, branched-chain pentanoate (9.2 MBq/mmol) were synthesized from the radio- amino as well as the corresponding 2-0x0 acids accumulate in active labeled N-acetyl derivatives of D-allo-isoleucine and D- MSUD (1-3). (S)-3-methyl-2-oxopentanoate, the transamination isoieucine, respectively (23, 24). Purity (>97%) and the specific product of L-isoleucine, can undergo racemization in vivo (4, 5). radioactivities of the products were examined by HPLC analysis The main metabolic fate of (R)-3-methyl-2-oxopentanoate thus as described above. Polarimetrically, impurities were not detect- formed appears to be transamination to L-allo-isoleucine which able. is regularly found in the patients blood (6-10). Cell culture. Human fibroblasts were obtained from skin biop- In most studies on kinetics and regulation of branched-chain sies of two normal subjects (strain RE and WE, mixed at equal 2-0x0 acid metabolism in human tissues, e.g. with homogenates portions for the assays) and of a patient (strain JA) with a variant of heart and skeletal muscle (1 l), mitochondria1 preparations form (intermittent type) of MSUD. Cells were multiplied in (12), and cultured intact and broken cells (1 3- 15), only 2-0x0 monolayer culture as described (17). After 10-20 passages, fibro- blasts at confluency were harvested by trypsinization, suspended Received May 29, 1987; accepted September 1, 1987. Correspondence Dr. Peter Schadewaldt, Institut fur Physiologische Chemie 11, in culture medium, washed twice with NaCl solution (0.154 moll Universitit Diisseldorf, Moorenstr. 5, D-4000 Dusseldorf, West Germany. Sup- liter), and resuspended in PBS, Dulbecco's modification (PBS), ported by Grant We 614/6-1 from the Deutsche Forschungsgemeinschaft. with bovine serum albumin (1.5 g/liter) and D-glucose (12.4 METABOLISM OF BRANCHED-CHAIN 2-OX0 ACIDS 4 1 mmol/liter). 0.4 ml of a suspension adjusted to about 2 x lo6 cells/ml was inserted into each assay. Mycoplasma contamina- tion tests (25) were negative. Incubations. I4CO2-tight 22-ml incubation flasks (1 1) were used to incubate fibroblasts (0.3-0.5 mg of cell protein) in a final volume of 0.9 ml PBS containing bovine serum albumin (0.07%, w/v), D-glucose (5.5 mmol/liter), and 2-oxo[ 1-I4C]acids as indi- cated. The reaction was started by addition of cell suspension and was stopped by injection of 0.5 ml sulfosalicylic acid (lo%, w/v). In blanks, cells were omitted. All samples were run in duplicate. Assays. I4CO2released during incubation was completely ab- sorbed in 0.5 ml ethanolamine-ethylenglycol(1:2,v/v) and meas- ured by liquid scintillation counting (1 1). I4CO2 recovery was checked with NaHI4CO3 solutions and counting efficiency by internal standardization with [14C]toluene. For the estimation of free amino acids, 0.1 ml DL-norleucine solution (0.1 mmol/liter) was then added to the medium and precipitated protein removed by centrifugation. One ml of the supernatant was freeze-dried and the residue dissolved in 0.5 ml LiOH solution (0.25 mol/liter, 2% 2.2'-thiodiethanol, w/v). The concentration of and radioactivity in amino acids were deter- mined on an automatic amino acid analyzer in runs with and without ninhydrin, respectively. Fig. 1. Time dependence of L-leucine production in incubations of For the determination of 14C-radioactivity in acid insoluble cultured human skin fibroblasts with 4-methyl-2-oxopentanoate (I material, the precipitate was thoroughly washed (5 x 1 ml) with mmol/liter). Cells derived from normal subjects were incubated at 37" C 3% sulfosalicylic acid (w/v), containing all branched-chain for 2-120 min. Sample content of free leucine was determined and amino (10 mmol/liter) and 2-0x0 acids (1 mmol/liter), by soni- corrected for the content in appropriate blanks with unincubated cells. cation and centrifugation and dissolved in 1 ml hydroxide of In the inset, the rate of leucine production is plotted against the incuba- hyamine 10x (Packard Instruments, Frankfurt). tion time. The respective rates were calculated from the differences of Protein concentrations (2.1 x 106 cells were equivalent to 1 leucine content and of the min elapsed between two successive incubation mg of cell protein) were estimated by the Lowry procedure (26), times. using bovine serum albumin as a standard. Calculations. Metabolic rates were calculated from the appro- priate 14C02liberation on the basis of the specific radioactivity of the CI-atom of the respective 2-oxo[14C]acid in the medium. Results are means + SD of the independent experiments per- formed on different days. Statistically significant differences were determined by Student's paired t test. RESULTS Time and concentration dependence. In incubations of normal fibroblasts in the absence of 2-0x0 acids, free amino acids (with the exception of aspartate) accumulated at gradually enhanced rates. The increase of leucine, valine, and isoleucine during O- 30 min of incubation amounted to 2.0 + 0.3, 2.7 + 0.4, and 0.9 E L + 0.3 nmol/mg of cell protein, and during 90-120 min to 3.7 2 0.4, 3.1 +. 0.4, and 1.5 + 0.5 nmol/mg of cell protein, respec- tively. The time course of leucine accumulation in incubations with 4-methyl-2-oxopentanoate (1 mmol/liter) is shown in Figure 1. The rate of formation declined up to 30 min of incubation and 0 C then remained constant up to the end of the experiment. With 0 - S- I~-'~c]KMV R- i 1-"C] KMV the other three branched-chain 2-0x0 acids, comparable effects on the accumulation of the corresponding branched-chain amino acids were found (data not shown).

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    5 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us